Hanlin Li
Impact in
- Pharmaceutical Science top 10%
- Drug Solubulity and Delivery Systems
- Analytical Chemistry top 10%
- Chromatography in Natural Products
Papers in
-
- RNA Interference and Gene Delivery 2
- Metabolomics and Mass Spectrometry Studies 2
-
- Crystallization and Solubility Studies 4
- Co-authors
- Qin Li (1 shared paper)Pat Sandra (1 shared paper)Guowang Xu (1 shared paper)Frédéric Lynen (1 shared paper)Jian Wang (1 shared paper)Gregory W. Sluggett (1 shared paper)Cai Yuan (7 shared papers)Longguang Jiang (6 shared papers)
- Journals
- International Journal of Biological Macromolecules (3 papers)The AAPS Journal (3 papers)Journal of Pharmaceutical and Biomedical Analysis (2 papers)Journal of Separation Science (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Hanlin Li
23 papers receiving 270 citations
Peers
Comparison fields: 5 of 85
- Pharmaceutical Science 47
- Analytical Chemistry 44
- Spectroscopy 71
- Molecular Biology 123
- Cancer Research 20
Countries citing papers authored by Hanlin Li
This map shows the geographic impact of Hanlin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanlin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanlin Li more than expected).
Fields of papers citing papers by Hanlin Li
This network shows the impact of papers produced by Hanlin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanlin Li. The network helps show where Hanlin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hanlin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 66 | |
| 2 | 2019 | 28 | |
| 3 | 2022 | 26 | |
| 4 | 2021 | 20 | |
| 5 | 2005 | 18 | |
| 6 | 2016 | 17 | |
| 7 | 2020 | 15 | |
| 8 | 2022 | 15 | |
| 9 | 2022 | 13 | |
| 10 | 2023 | 8 | |
| 11 | 2024 | 7 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2025 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 6 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 3 |
About Hanlin Li
Hanlin Li is a scholar working on Molecular Biology, Materials Chemistry, Pharmaceutical Science, Biomaterials and Complementary and alternative medicine, having authored 23 papers that have together received 281 indexed citations. Recurring topics across this work include Crystallization and Solubility Studies (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Drug Solubulity and Delivery Systems (3 papers), Protease and Inhibitor Mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Computational Drug Discovery Methods (2 papers) and Chromatography in Natural Products (2 papers). The work is most often cited by research in Pharmaceutical Science (47 citations), Analytical Chemistry (44 citations), Spectroscopy (71 citations), Molecular Biology (123 citations) and Cancer Research (20 citations). Hanlin Li has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Qin Li, Pat Sandra, Guowang Xu, Frédéric Lynen, Jian Wang, Gregory W. Sluggett, Cai Yuan, Longguang Jiang, Christopher M. Riley and Mingdong Huang. Their work appears in journals such as International Journal of Biological Macromolecules, The AAPS Journal, Journal of Pharmaceutical and Biomedical Analysis, Journal of Separation Science and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.